Renal Mass Registry
Condition: Renal Cell Carcinoma
Intervention:
- Other: questionnaire
Purpose: Collect valuable risk factor and quality of life data from Renal Cell Carcinoma patients and harness the latest technology to organize and analyze data.
Study Type: Interventional
Clinical Trials Identifier NCT 8-digits: NCT01887574
Sponsor: Mayo Clinic
Primary Outcome Measures:
- Measure: Evidence of Renal Mass Risk Factors as determined by patient questionnaire post surgery
- Time Frame: 5 years
- Safety Issue:
Estimated Enrollment: 5000
Study Start Date: June 2013
Eligibility:
- Age: minimum 18 Years maximum N/A
- Gender: All
Criteria: Inclusion: – Patients with a renal mass or a suspected metastatic lesion from a renal primary who have been treated or are going to be studied and or treated surgically at Mayo Clinic Arizona – Patients must be 18 years of age or older – Patients must be capable of and willing to sign an informed consent Exclusion: None
Location:
- Mayo Clinic in Arizona
- Scottsdale Arizona 85259 United States
View trial on ClinicalTrials.gov